# Sumitomo Osaka Cement Co.,Ltd. – FDA Inspection, Jun 29, 2017

Source: https://www.keypedia.com/records/fda_inspections/sumitomo-osaka-cement-coltd/30df9c0f-49f8-4016-a517-3cdad4d9a315
Source feed: FDA_Inspections

> FDA inspection 1016543 of Sumitomo Osaka Cement Co.,Ltd., June 29, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 11. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1016543
- Company Name: Sumitomo Osaka Cement Co.,Ltd.
- Inspection Date: 2017-06-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1224072 - 2023-10-27](https://www.keypedia.com/records/fda_inspections/sumitomo-osaka-cement-coltd/ea9732c3-d73e-407f-aea9-741381b56293)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/patty-p-kaewussdangkul/1f0961fc-216e-4580-830a-56a76c0e7cea)

Company: https://www.keypedia.com/companies/sumitomo-osaka-cement-coltd/b155539c-7ed7-44ed-85fb-25006860bc19

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c